Valuation: Renalytix Plc

Market Cap 13.34M 11.56M 10.82M 9.87M 18.58M 1.27B 18.89M 127M 49.71M 637M 50.07M 48.98M 2.12B P/E 2024
-0.45x
P/E 2025 -1.34x
Enterprise Value 17.94M 15.54M 14.55M 13.28M 24.98M 1.71B 25.4M 171M 66.85M 856M 67.34M 65.88M 2.86B EV / Sales 2024
11,059,330x
EV / Sales 2025 12,499,418x
Free-Float
73.31%
Yield 2024 *
-
Yield 2025 -
1 day-2.09%
1 week+33.65%
Current month+58.87%
1 month+50.36%
3 months+133.89%
6 months+3.95%
Current year-28.64%
1 week 3
Extreme 3
5
1 month 2.3
Extreme 2.3
5
Current year 1.6
Extreme 1.6
6.5
1 year 1.6
Extreme 1.6
15.5
3 years 1.6
Extreme 1.6
125
5 years 1.6
Extreme 1.6
1,075
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 15/03/2018
Director of Finance/CFO 68 28/05/2024
President 65 30/04/2024
Director TitleAgeSince
Chairman 62 05/11/2024
Director/Board Member 58 15/03/2018
Chairman 74 -
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Founder

500 0.0001%
2/13/26 A Buy

Founder

250 0.0001%
2/13/26 A Buy

Chief Financial Officer

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.09%+33.65%-32.64%-95.99% 25.39M
-1.05%+3.19%+19.81%-35.41% 17.18B
+5.67%-4.35%-8.22%+93.62% 1.76B
-0.54%+1.47%-25.04%+21.39% 1.01B
+1.75%-20.42%-40.82%-82.05% 959M
+0.65%+50.20%+90.17%-10.84% 783M
-0.79%+1.34%-38.61%-51.45% 677M
+5.71%+8.80%-45.54%-45.92% 595M
-0.67%+4.84%-45.11%-42.16% 415M
+13.75%+18.46%+55.68%+38.83% 411M
Average +2.22%+11.63%-7.03%-21.00% 2.38B
Weighted average by Cap. +0.07%+4.75%+11.85%-24.18%

Financials

2024 2025
Net sales 2.29 1.98 1.86 1.69 3.19 218.32 3.24 21.77 8.53 109.28 8.59 8.41 364.56 3 2.6 2.43 2.22 4.18 286.14 4.25 28.54 11.18 143.22 11.26 11.02 477.8
Net income -33.46M -28.99M -27.14M -24.77M -46.6M -3.19B -47.39M -318M -125M -1.6B -126M -123M -5.33B -20.4M -17.68M -16.55M -15.1M -28.42M -1.95B -28.89M -194M -76.03M -974M -76.6M -74.93M -3.25B
Net Debt 3.86M 3.34M 3.13M 2.85M 5.37M 368M 5.46M 36.67M 14.37M 184M 14.47M 14.16M 614M 4.6M 3.99M 3.73M 3.41M 6.41M 439M 6.52M 43.76M 17.14M 220M 17.27M 16.9M 733M
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
12/08/26 GBX 4.210 -2.09% 748,446
11/08/26 GBX 4.300 -5.49% 1,047,931
10/08/26 GBX 4.550 +22.97% 7,923,085
07/08/26 GBX 3.700 +13.85% 3,853,564
06/08/26 GBX 3.250 +3.17% 584,873

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENX Stock